DT&CRO CO., Ltd.

KOSDAQ:A383930 Stock Report

Market Cap: ₩23.4b

DT&CRO Past Earnings Performance

Past criteria checks 0/6

DT&CRO's earnings have been declining at an average annual rate of -37.7%, while the Life Sciences industry saw earnings declining at 3.1% annually. Revenues have been growing at an average rate of 11.3% per year.

Key information

-37.65%

Earnings growth rate

-52.72%

EPS growth rate

Life Sciences Industry Growth53.72%
Revenue growth rate11.25%
Return on equity-108.57%
Net Margin-25.71%
Last Earnings Update31 Mar 2026

Recent past performance updates

No updates

Recent updates

Analysis Article Dec 30

Benign Growth For DT&CRO CO., Ltd. (KOSDAQ:383930) Underpins Stock's 25% Plummet

DT&CRO CO., Ltd. ( KOSDAQ:383930 ) shares have had a horrible month, losing 25% after a relatively good period...
Analysis Article Nov 15

Why Investors Shouldn't Be Surprised By DT&CRO CO., Ltd.'s (KOSDAQ:383930) Low P/S

DT&CRO CO., Ltd.'s ( KOSDAQ:383930 ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right...
Analysis Article Aug 01

DT&CRO CO., Ltd.'s (KOSDAQ:383930) Price Is Right But Growth Is Lacking

With a price-to-sales (or "P/S") ratio of 1.1x DT&CRO CO., Ltd. ( KOSDAQ:383930 ) may be sending very bullish signals...

Revenue & Expenses Breakdown

How DT&CRO makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A383930 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2647,768-12,2817,4710
31 Dec 2547,747-2,7777,4440
30 Sep 2544,3574,1733,5370
30 Jun 2542,3004,2992,6310
31 Mar 2539,499-1,6403,4230
31 Dec 2435,971-1,9993,4760
30 Sep 2425,100-24,48010,9090
30 Jun 2421,264-25,40311,0690
31 Mar 2422,699-22,33810,2400
31 Dec 2326,586-16,6369,2530
30 Sep 2336,529-3,4964,8380
30 Jun 2340,2017494,6360
31 Mar 2344,0054,8003,7060
31 Dec 2244,0085,2563,3560
30 Sep 2242,6856,7892,8630
30 Jun 2241,7097,1842,4230
31 Mar 2236,2155,5752,4170
31 Dec 2132,7494,3282,3850
31 Dec 2020,089-1,3961,5330
31 Dec 1910,587-2,0531,2370

Quality Earnings: A383930 is currently unprofitable.

Growing Profit Margin: A383930 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A383930 is unprofitable, and losses have increased over the past 5 years at a rate of 37.7% per year.

Accelerating Growth: Unable to compare A383930's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A383930 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-26.7%).


Return on Equity

High ROE: A383930 has a negative Return on Equity (-108.57%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/14 22:07
End of Day Share Price 2026/08/14 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DT&CRO CO., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.